Market Research Logo

Medical Imaging Markets: Contrast Agents (X-Ray, CT, Ultrasound, MRI, PET, SPECT)

Today’s capabilities in clinical diagnostic radiology have been made possible by advances not only in diagnostic systems, but also by the contrast media and radiopharmaceuticals that make it possible to see, in great detail, the body’s internal structures, organs and tissue that would nototherwise be clearly seen. Although bones are readily apparent on radiographic images, other organs and tissues are not. These imaging agents may be usedduring a medical imaging procedure to highlight specific parts of the body andmake them easier to visualize.  The application and versatility of medical imaging modalities are continuing to grow in significance as the population ages and healthcare costs rise.   Examinations that can facilitate earlier disease diagnosis and the most appropriate treatment are in order. This bodes well for contrast media markets.

Generally, the market for contrast agents and radiopharmaceuticals is expected to sustain decent growth in the next fewyears, with much of that growth coming from the MRI, ultrasound and nuclear medicine modalities. While equipment manufacturers may have experienced a slumpin sales due to the recent recession, there is still a need for these agents,as well as for radiopharmaceuticals, to help image, track and diagnose disease, especially in the elderly. Even though hospitals and clinics may have slowed their equipment purchases because of the need to contain costs, procedures run on installed systems still require the use of contrast agents and radiopharmaceuticals.

This comprehensive study of the world market for contrast agents builds on the previous modality-focused reports of Kalorama's medical imaging market reports. Coverage includes:

  • World and regional revenue forecasts for contrast agents and radiopharmaceuticals by modality through 2016. (X-Ray, CT, Ultrasound, MRI, PET, SPECT)
  • Market share of the major contrast agent supplers
  • Procedure volumes by modality and region
  • Estimates of the portion of procedures in each modality using contrast enhancement
  • Contrast-enhancement products in development

The report also discusses technical developments and emerging application trends such as therapeutic monitoring, whole body screening, and guided therapeutic interventions, and how contrast agents are helping to expand imaging’s role in basic research and drug discovery/development. Specific advances in contrast agent-enabled diagnostics for mammography, Alzheimer’s, and other indications are also reviewed.

The report concludes with profiles of top suppliers and developers including:

  • Acusphere Inc.
  • Alseres Pharmaceuticals Inc.
  • Amag Pharmaceuticals Inc.
  • Aposense Ltd.
  • Avid Radiopharmaceuticals Inc.
  • Bayer Schering Pharma
  • Bracco SpA
  • Cell Point
  • Covidien Ltd.
  • Daiichi Pharmaceutical Co. Ltd.
  • Dendritic NanoTechnologies Inc.
  • Draximage
  • Endocyte Inc.
  • Eusa Pharma
  • GE Healthcare
  • Guerbet Group
  • Hovione FarmaCiencia SA
  • Imcor Pharmaceutical Co.
  • Immunomedics Inc.
  • Insight Agents GmbH
  • King Pharmaceuticals Inc.
  • Luna nanoWorks
  • Macrocyclics
  • MDS Nordion
  • NanoScan Imaging
  • Palatin Technologies Inc.
  • Pharmacyclics
  • Point Biomedical Corp.
  • Starpharma Holdings Ltd.
  • VisEn Medical Inc.


  • Executive Summary
    • IMAGE ENHANCEMENT OVERVIEW
      • X-Ray and CT
      • Ultrasound
      • MRI
      • Radiopharmaceuticals
    • WORLD MARKET SUMMARY
    • VOLUME GROWTH
      • New Diagnostics
      • Toxicity Issues
      • Generic Competition
    • WORLD MARKET GROWTH ANALYSIS
      • Table World Market for X-Ray Medical Contrast Media, 2011-2015 Revenues (billions)
      • Table World Market for CT Medical Contrast Media, 2011-2015 Revenues (billions)
      • Table World Market for Ultrasound Medical Contrast Media, 2011-2015 Revenues (billions)
      • Table World Market for MRI Medical Contrast Media, 2011-2015 Revenues (billions)
      • Table World Market for PET Radiopharmaceuticals, 2011-2015 Revenues (billions)
      • Table World Market for SPECT Radiopharmaceuticals, 2011-2015 Revenues (billions)
    • METHODOLOGY
  • Introduction
    • AGENTS FOR THE EARLY DETECTION OF DISEASE
    • TWO FUNCTIONS
    • ADDING VALUE
    • KEY CLINICAL MARKETS
      • Table Key Medical Contrast Agents by Type
      • X Ray and CT
      • Ultrasound
    • UPDATED WARNING ON MICROBUBBLES
    • MICROBUBBLE COMPOSITION
      • Targeted and Untargeted
      • MRI
      • Novel Agents
      • Nuclear Medicine
      • Diagnosing Functionality
      • Sourcing Issues Updated
      • PET
    • NEW APPLICATIONS
      • SPECT
      • Gamma Cameras
    • RISKS
      • Ionic and Non-Ionic Contrast
        • Table Advantages of Non-Ionic Contrast Media
    • ISSUES
      • Utilization Rate
    • TECHNICAL CHALLENGES
    • TRACKING CONTRAST MEDIA
      • Contrast Modality Combinations
    • EMERGING APPLICATIONS
      • Atherosclerosis
      • Nanotechnology
  • Market Developments
    • FDA APPROVES AMYVID
    • BAYER HEALTHCARE BUSINESS INTEGRATION
      • Bayer Receives Gadavist Approval
    • AGFA'S GENERIC PUSH
      • IMPROVING MAGNETIC RESONANCE VISUALIZATION
    • NANOPARTICLE CONTRAST
    • TRACKING STEM CELLS
  • Markets
    • MARKET DRIVERS
      • Table Patent Status of Selected Medical Imaging Agents
    • WITHSTANDING THE RECESSION
      • Table World Market for Medical Contrast Media and Radiopharmaceuticals, 2011-2015 Revenues (in billions)
    • COMBINATION IMAGING AND DISEASE MANAGEMENT
    • OPPORTUNITIES FROM INCREASING SPECIFICITY
    • AGING POPULATION
      • Utilization
      • Procedures
        • Table World Market Geographic Segmentation for Medical X-Ray Procedures, 2012
        • Table Worldwide Medical MRI Procedures, 2012
        • Table Worldwide Medical CT Procedures, 2012
        • Table Worldwide Medical Ultrasound Procedures, 2012
        • Table Worldwide Medical PET Procedures, 2012
        • Table Worldwide Medical SPECT Procedures, 2012
    • OUTLOOK FOR CONTRAST MEDIA
      • Table Status of Selected Medical Imaging Agents
    • MARKET FORECAST
      • X-ray and CT
        • Table World Market for X-Ray Contrast Media, 2011-2015 Revenues (in billions)
        • Table World Market for Medical X-Ray Contrast Media by Geographic Segment, 2011-2015 Revenues (in billions)
        • Table World Market for CT Contrast Media, 2011-2015 Revenues (in billions)
        • Table World Market for Medical CT Contrast Media by Geographic Segment 2011-2015 Revenues (in billions)
      • Ultrasound
        • Table World Market for Ultrasound Contrast Media, 2011-2015 Revenues (in billions)
        • Table World Market for Medical Ultrasound Contrast Media by Geographic Segment, 2011-2015 Revenues (in billions)
      • MRI
        • Table World Market for MRI Contrast Media, 2011-2015 Revenues (in billions)
        • Table World Market for Medical MRI Contrast Media by Geographic Segment, 2011-2015 Revenues (in billions)
    • OUTLOOK FOR MOLECULAR IMAGING AGENTS
    • MARKET FORECAST
      • Table Selected Molecular Imaging Products
      • Table World Market for Medical PET Radiopharmaceuticals, 2011-2015 Revenues (in billions)
      • Table World Market for Medical PET Radiopharmaceuticals by Geographic Segment, 2011-2015 Revenues (in billions)
      • Table World Market for Medical SPECT Radiopharmaceuticals, 2011-2015 Revenues (in billions)
      • Table World Market for Medical SPECT Radiopharmaceuticals by Geographic Segment, 2011-2015 Revenues (in billions)
  • Corporate Profiles
    • Acusphere Inc.
    • Alseres Pharmaceuticals Inc.
    • Amag Pharmaceuticals Inc.
    • APOSENSE LTD.
    • ART Advanced Research Technologies Inc.
    • Avid Radiopharmaceuticals Inc.
    • Bayer HealthCare
    • Bracco SpA
    • Cardinal Health
    • Cell>Point
    • Covidien plc
    • Daiichi Pharmaceutical Co. Ltd.
    • Draximage
    • Endocyte Inc.
    • Eusa Pharma
    • FluoroPharma Medical Inc.
    • GE Healthcare
    • Guerbet Group
    • HOVIONE FARMACIENCIA SA
    • Immunomedics Inc.
    • INSIGHT AGENTS
    • KEREOS INC.
    • KING PHARMACEUTICALS
    • LANTHEUSMEDICAL IMAGING
    • LUNA NANOWORKS
    • MACROCYCLICS
    • MDS NORDION
    • MOLECULAR INSIGHT PHARMACEUTICALS INC.
    • NANOSCAN IMAGING LLC
    • PALATIN TECHNOLOGIES INC.
    • PHARMACYCLICS
    • SPAGO IMAGING AB
    • TARGESON INC.
    • TAEJOON PHARMACEUTICAL CO. LTD.
    • VISEN MEDICAL
    • ZIM LABORATORIES INDIA LTD.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report